Stay updated on Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page.

Latest updates to the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page
- Check3 days agoChange DetectedTwo new sections, Contacts/Locations and Study Status, were added to the study history page on 2026-07-07, improving access to contact details and the current study status. A prior entry from 2026-06-22 was removed from the history.SummaryDifference0.3%

- Check10 days agoChange DetectedA new revision entry (v3.6.3) was added to the history, replacing the previous v3.6.2. This indicates an incremental update to the study record's documentation.SummaryDifference0.1%

- Check17 days agoChange DetectedA new version entry (38) is added to the record history, including updates to Study Status and Contacts/Locations and recorded as Revision: v3.6.2. The previous revision (v3.6.0) was removed.SummaryDifference0.4%

- Check31 days agoChange DetectedThe history adds a new note stating 'No longer looking for participants' and records the revision as v3.6.0. The previous revision tag v3.5.5 is removed from the history.SummaryDifference0.3%

- Check38 days agoChange DetectedA new history entry appears: Revision: v3.5.5, and the previous Revision: v3.5.4 is removed from the list, indicating a minor update to the page's version history. This change updates the page’s historical record without altering the study data.SummaryDifference0.1%

- Check52 days agoChange DetectedOn 2026-05-19, Contacts/Locations and Study Status were added to the record history. The version count is shown as 37, and the entry from 2026-04-17 was removed.SummaryDifference0.3%

Stay in the know with updates to Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page.